Interest in the Use of Dressings With Honey for Wound Healing After Excision of Pilonidal Cyst

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

890 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-03-08

Study Completion Date

2022-02-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The management of pilonidal cysts is a skin excision and under deep skin. Scarring requires regular dressings (daily for 15 days and then every 48 hours) until complete healing. This healing is obtained on average in 68 days. Some patients have difficulties in healing with a final healing achieved on average in 95 days. Some teams use honey to promote wound cavitary wounds (wound infection, pressure ulcers, varicose wound). The acceleration of wound healing is due to antibacterial properties and hyperosmolarity to reduce secretions. ) The use of honey in pilonidal cysts is not evaluated and may accelerate healing.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluation of the Healing of the Pilonidal Cyst After 1940 nm Laser Treatment

NCT07269548

Pilonidal Cyst/Fistula

RECRUITING

Pilonidal Disease Wound Healing Study

NCT01857128

Pilonidal Disease

UNKNOWN PHASE4

Comparison of the Effectiveness of the Simple Puncture Compared to the Incision of an Abscess on the PiLOnidal Sinus

NCT06378918

Pilonidal Cyst

RECRUITING NA

Excision and Reconstruction of the Natal Cleft With a Parasacral Perforator Flap Versus Open Excision With Secondary Healing, in the Management of Sacrococcygeal Pilonidal Disease.

NCT03534700

Pilonidal Disease

TERMINATED NA

Feasibility of a Novel Technique for Pilonidal Wound Healing

NCT02330159

Pilonidal Disease Pilonidal Cyst Pilonidal Sinus

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pilonidal Cysts

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

standard dressings

In general, the dressings made are either of the type :

* Algosteril® (round or flat wick) + Mepilex® border
* or AquacelTM ExtraTM + AquacelTM Foam

Group Type NO_INTERVENTION

No interventions assigned to this group

standard dressings with sterile honey

Melectis G

Group Type EXPERIMENTAL

Melectis G

Intervention Type DEVICE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Melectis G

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Cavity Wound to 6 weeks of a pilonidal cyst excision
* Bloodless wound
* Pilonidal cyst not recurred
* Age : 18 years and older
* Signature of informed consent
* In the capacity to understand the study

Exclusion Criteria

* Bleeding wound
* Refused to participate in Protocol
* Patient immunocompromised
* Recurrent pilonidal cyst
* Patients on long-term corticosteroid
* Patient deprived of liberty, under guardianship
* Patient unable to understand the study
* Allergy or hypersensitivity to honey
* Allergy Or hypersensitivity to hyaluronic acid
* Allergy or hypersensitivity to guar gum
* Allergy or hypersensitivity to pectin
* Known allergy to propolis (potentially present in honey)
* Sensitivity to zinc oxide
* Sensitivity known dressings used in this trial or any component
* Diabetes Non-insulin or insulin

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No